179 related articles for article (PubMed ID: 22853450)
1. A topical aqueous calcineurin inhibitor for the treatment of naturally occurring keratoconjunctivitis sicca in dogs.
Gilger BC; Wilkie DA; Salmon JH; Peel MR
Vet Ophthalmol; 2013 May; 16(3):192-7. PubMed ID: 22853450
[TBL] [Abstract][Full Text] [Related]
2. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.
Berdoulay A; English RV; Nadelstein B
Vet Ophthalmol; 2005; 8(4):225-32. PubMed ID: 16008701
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs.
Olivero DK; Davidson MG; English RV; Nasisse MP; Jamieson VE; Gerig TM
J Am Vet Med Assoc; 1991 Oct; 199(8):1039-42. PubMed ID: 1748606
[TBL] [Abstract][Full Text] [Related]
4. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
Moore CP; McHugh JB; Thorne JG; Phillips TE
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):653-9. PubMed ID: 11222523
[TBL] [Abstract][Full Text] [Related]
5. Effect of once daily topical 0.3% naltrexone on tear parameters and corneal sensitivity in dogs with uncontrolled keratoconjunctivitis sicca: a double-masked randomized placebo-controlled clinical trial.
Chen T; Powell CC
Vet Ophthalmol; 2015 Nov; 18(6):497-501. PubMed ID: 25675975
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of topical oclacitinib 0.1% and tacrolimus 0.01% in canine keratoconjunctivitis sicca.
de Oliveira JK; Williams DL; Bollmann C; de Seabra NM; Bortolini M; Montiani-Ferreira F
Vet Ophthalmol; 2019 Sep; 22(5):633-643. PubMed ID: 30724448
[TBL] [Abstract][Full Text] [Related]
7. Low-dose oral administration of interferon-alpha for the treatment of immune-mediated keratoconjunctivitis sicca in dogs.
Gilger BC; Rose PD; Davidson MG; Roberts SM; Miller T
J Interferon Cytokine Res; 1999 Aug; 19(8):901-5. PubMed ID: 10476936
[TBL] [Abstract][Full Text] [Related]
8. The pharmacologic assessment of a novel lymphocyte function-associated antigen-1 antagonist (SAR 1118) for the treatment of keratoconjunctivitis sicca in dogs.
Murphy CJ; Bentley E; Miller PE; McIntyre K; Leatherberry G; Dubielzig R; Giuliano E; Moore CP; Phillips TE; Smith PB; Prescott E; Miller JM; Thomas P; Scagliotti R; Esson D; Gadek T; O'Neill CA
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3174-80. PubMed ID: 21330663
[TBL] [Abstract][Full Text] [Related]
9. Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
Izci C; Celik I; Alkan F; Erol M; Sur E
Biotech Histochem; 2015 Apr; 90(3):223-30. PubMed ID: 25747049
[TBL] [Abstract][Full Text] [Related]
10. Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.
Barachetti L; Rampazzo A; Mortellaro CM; Scevola S; Gilger BC
Vet Ophthalmol; 2015 May; 18(3):234-41. PubMed ID: 24799029
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A.
Ofri R; Lambrou GN; Allgoewer I; Graenitz U; Pena TM; Spiess BM; Latour E
Vet J; 2009 Jan; 179(1):70-7. PubMed ID: 17950639
[TBL] [Abstract][Full Text] [Related]
12. Analysis of tear uptake by the Schirmer tear test strip in the canine eye.
Williams DL
Vet Ophthalmol; 2005; 8(5):325-30. PubMed ID: 16178843
[TBL] [Abstract][Full Text] [Related]
13. Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs.
Morgan RV; Abrams KL
J Am Vet Med Assoc; 1991 Oct; 199(8):1043-6. PubMed ID: 1748607
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.
Kaswan RL; Salisbury MA; Ward DA
Arch Ophthalmol; 1989 Aug; 107(8):1210-6. PubMed ID: 2757551
[TBL] [Abstract][Full Text] [Related]
15. The effects of topical aqueous sirolimus on tear production in normal dogs and dogs with refractory dry eye.
Spatola R; Nadelstein B; Berdoulay A; English RV
Vet Ophthalmol; 2018 May; 21(3):255-263. PubMed ID: 28972684
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Periocular Fatty Acids and 0.15% Hyaluronate Eye Drops Application on Keratoconjunctivitis Sicca in Dogs: An Exploratory Study.
Amalfitano C; Pasolini MP; Nieddu A; Della Valle G; Fiorentin PG; Lamagna F; Lamagna B
Top Companion Anim Med; 2019 Jun; 35():18-25. PubMed ID: 31122683
[TBL] [Abstract][Full Text] [Related]
17. Assessment of tear film osmolarity using the TearLab
Sebbag L; Park SA; Kass PH; Maggs DJ; Attar M; Murphy CJ
Vet Ophthalmol; 2017 Jul; 20(4):357-364. PubMed ID: 27761982
[TBL] [Abstract][Full Text] [Related]
18. Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca.
Izci C; Celik I; Alkan F; Ogurtan Z; Ceylan C; Sur E; Ozkan Y
Am J Vet Res; 2002 May; 63(5):688-94. PubMed ID: 12013470
[TBL] [Abstract][Full Text] [Related]
19. Retrospective study of the prevalence of keratoconjunctivitis sicca in diabetic and nondiabetic dogs after phacoemulsification.
Gemensky-Metzler AJ; Sheahan JE; Rajala-Schultz PJ; Wilkie DA; Harrington J
Vet Ophthalmol; 2015 Nov; 18(6):472-80. PubMed ID: 25429857
[TBL] [Abstract][Full Text] [Related]
20. Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca.
Radziejewski K; Balicki I
Acta Vet Hung; 2016 Sep; 64(3):313-329. PubMed ID: 27653428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]